That would have to involve profit, not just revenue. Does Meir actually believe they will generate enough funds to cover operational expenses plus construction of a new batch & launch? I would have thought that to be an unlikely achievement after just the initial batch.
- Forums
- ASX - By Stock
- SAS
- Just spoke to Meir...
Just spoke to Meir..., page-43
-
- There are more pages in this discussion • 32 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SAS (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online